Endothelin-receptor antagonism: the future is bright. Lancet [Lancet] Journal article

Title	Endothelin-receptor antagonism: the future is bright.
Author(s)	Dhaun N, Webb DJ
Institution	Queen's Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK. bean.dhaun@ed.ac.uk
Source	Lancet 2008 Jun 21; 371(9630):2061-2.
MeSH	Antihypertensive Agents Humans Hypertension, Pulmonary Randomized Controlled Trials as Topic Receptors, Endothelin Severity of Illness Index Sulfonamides
Language	eng
Pub Type(s)	Comment Journal Article
PubMed ID	18572063

Advertise on this site.